Next Article in Journal
Detection of Anti-SARS-CoV-2-S1 RBD-Specific Antibodies Prior to and during the Pandemic in 2011–2021 and COVID-19 Observational Study in 2019–2021
Next Article in Special Issue
The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates
Previous Article in Journal
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia
Previous Article in Special Issue
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases
 
 
Communication

Article Versions Notes

Vaccines 2022, 10(4), 580; https://doi.org/10.3390/vaccines10040580
Action Date Notes Link
article xml file uploaded 9 April 2022 14:49 CEST Original file -
article xml uploaded. 9 April 2022 14:49 CEST Update https://www.mdpi.com/2076-393X/10/4/580/xml
article pdf uploaded. 9 April 2022 14:49 CEST Version of Record https://www.mdpi.com/2076-393X/10/4/580/pdf
article html file updated 9 April 2022 14:51 CEST Original file https://www.mdpi.com/2076-393X/10/4/580/html
Back to TopTop